Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

The modification of the liposomal surface by incorporating negatively charged lipids (e.g., by dicetylphosphate [DCP] incorporation), seems to increase the AM affinity to capture anionic liposomes via ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers joining in ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

ATLANTA - Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren't infectious, after investigators found a new combination of pills knocks out the disease ...

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis ...

ETHealthworld.com brings latest tb treatment news, views and updates from all top sources for the Indian Health industry.

TB is an infectious disease that is far from being eradicated and controlled. The treatment for TB is associated with noncompliance to therapy because it consists of a long-term treatment with a ...